Nimodipine, a Centrally Active Calcium Antagonist, Exerts a Beneficial Effect on Contrast Sensitivity in Patients with Normal-tension Glaucoma and in Control Subjects
Open Access
- 1 August 1995
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 102 (8) , 1236-1241
- https://doi.org/10.1016/s0161-6420(95)30884-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- NimodipineDrugs & Aging, 1992
- Isolating the Effects of Primary Open-angle Glaucoma on the Contrast Sensitivity FunctionAmerican Journal of Ophthalmology, 1991
- Association of Vistech contrast sensitivity and visual field findings in glaucoma.British Journal of Ophthalmology, 1991
- Pharmacology of NimodipineAnnals of the New York Academy of Sciences, 1988
- Response of Blood Flow to Warm and Cold in Normal and Low-Tension Glaucoma PatientsAmerican Journal of Ophthalmology, 1988
- Clinical Measures of Central Vision Function in Glaucoma and Ocular HypertensionArchives of Ophthalmology (1950), 1987
- Correlation of Color Vision Deficits and Observable Changes in the Optic Disc in a Population of Ocular HypertensivesArchives of Ophthalmology (1950), 1984
- Contrast sensitivity and visual disability in chronic simple glaucoma.British Journal of Ophthalmology, 1984
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Abnormalities of Central Contrast Sensitivity in GlaucomaAmerican Journal of Ophthalmology, 1979